Shawn Singh - Aug 17, 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol: VTGN
Transactions as of: Aug 17, 2022
Transactions value $: $103,200
Form type: 4
Date filed: 8/18/2022, 03:56 PM
Previous filing: Jul 15, 2022
Next filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTGN	Common Stock	Purchase	$103K	+600K	+2287.11%	$0.17	626K	Aug 17, 2022	By The 1997 Singh Family Trust U/R/D 05/29/97	F1
holding	VTGN	Common Stock						154K	Aug 17, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1600 to $0.1975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1600 to $0.1975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.